Skip to content

The effects of depth of volatile general anaesthesia, measured by bispectral index (BIS), on post-operative pain.

The effects of depth of volatile general anaesthesia, measured by bispectral index (BIS), on post-operative pain.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000350224
Enrollment
150
Registered
2009-05-25
Start date
2009-12-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Recent studies have shown that the amount of general anaesthesia administered during an operation may influence pain and pain relief needed after surgery. We plan to use a brain monitor called bispectral index (BIS) to investigate a possible relationship between general anaesthesia and pain after surgery. We also plan to further investigate whether differing intensity of post-operative pain is influenced by either different genetic sensitivity to pain, or the body excreting fentanyl more quickly.

Interventions

The treatment group will receive deeper planes of volatile general anaesthesia for the duration of surgery with a bispectral index (BIS) targeted at 30-40. (ie the dose of volatile general anaesthesia will be titrated to the BIS)

Sponsors

Dr Matthew Scott
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Patients scheduled for elective surgery with a non-malignant diagnosis, aged 18-65 years, American Society of Anaesthesiologists score (ASA) 1 or 2, competent to consent to participation, able to use and visual analogue scale (VAS) and able to activate a patient controlled analgesia (PCA) machine post-operatively.

Exclusion criteria

Emergency surgery Age greater than 65 years Age less than 18 years. ASA 3 or above. Inability to consent or lack of written consent Inability to speak English fluently Malignancy diagnosed or suspected pre-operatively Epilepsy, neuromuscular disease, psychiatric illness or COPD with carbon dioxide retention Pre-operative chronic opioid use Morphine allergy, allergy to drugs used as part of the standardised general anaesthetic, history of malignant hyperthermia Use of regional anaesthesia or neuraxial blockade (or request for regional anaesthesia by patient) Use of TIVA rather than volatile general anaesthesia Protocol broken intra-operatively (or post-operatively) Return to theatre for re-operation within 48 hours Pregnancy Severe asthma Expected duration of surgery > 3 hours (180 minutes) Obesity (Weight > 120kg or body mass index (BMI) >35 kg/m2)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026